Overview

A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
0
Participant gender:
All
Summary
The management of latent Mycobacterium tuberculosis infection is a new priority action for the WHO End Tuberculosis (TB) Strategy. However, national guidelines on latent tuberculosis infection testing and treatment have not yet been developed in children of China. Here, we present the results from the 3-year follow-up of a study that aimed to track the development of active disease in individuals with latent tuberculosis infection, identify priority populations for latent infection management, and explore the most suitable latent infection diagnostic approach.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Beijing Children's Hospital
Criteria
Inclusion Criteria:

- Children (0-18 years old).

- Children with QFT-positive or TST induration ≥10 mm).

Exclusion Criteria:

- Patients are allergic to anti-tuberculsis drugs.

- Parents and/or guardians do not agree to participate in this study.

- Participants with active tuberculosis.